(Q52721765)
Statements
Use of a physiologic pharmacokinetic model of glucose homeostasis for assessment of performance requirements for improved insulin therapies. (English)
Sorensen JT
Colton CK
Hillman RS
Soeldner JS
1 May 1982
5
3
148-157